ArticleCurrent microbiology2025
Statistical Optimization of Exopolysaccharide and Biomass Production by Mangrove Fungi Fusarium equiseti ANP2 and its Potential Application as Bioemulsifier and Chelator.
Article in Current microbiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
The rationale of the study is to explore the bio functional industrial potential and optimized culture conditions of a Manno glucan heteropolysaccharide MF-1 (purified EPS fraction) produced by a newly discovered mangrove derived fungi Fusarium equiseti ANP2, isolated from the Krishna River delta mangrove sediments. Response surface methodology (RSM) was employed to optimize fungal EPS and Biomass production, achieving a significant 1.4-fold increase to 6.94 g/L in EPS yield and a 2.1-fold increase in biomass production. RSM identified optimal levels of glucose, NH₄NO₃, NaCl, leucine, temperature, and pH, while minimizing the required glucose and nitrogen content compared to conventional methods. Notably, MF-1 exhibited promising emulsification potential (69.5% n-hexadecane emulsification), suggesting its prospective role as a novel emulsifier, particularly for n-hexadecane-based applications. Additionally, MF-1 also displayed a chelating activity for Fe
Indexed as
Identifiers
40080213What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.